- Home
- MHK vs ASND Comparison
MHK vs ASND Comparison
Compare MHK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- ASND
- Stock Information
- Founded
- MHK 1988
- ASND 2006
- Country
- MHK United States
- ASND Denmark
- Employees
- MHK N/A
- ASND N/A
- Industry
- MHK Home Furnishings
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MHK Consumer Discretionary
- ASND Health Care
- Exchange
- MHK Nasdaq
- ASND Nasdaq
- Market Cap
- MHK 8.8B
- ASND 7.7B
- IPO Year
- MHK 1992
- ASND 2015
- Fundamental
- Price
- MHK $125.95
- ASND $140.20
- Analyst Decision
- MHK Buy
- ASND Strong Buy
- Analyst Count
- MHK 13
- ASND 13
- Target Price
- MHK $159.23
- ASND $191.77
- AVG Volume (30 Days)
- MHK 636.6K
- ASND 427.4K
- Earning Date
- MHK 02-06-2025
- ASND 02-05-2025
- Dividend Yield
- MHK N/A
- ASND N/A
- EPS Growth
- MHK N/A
- ASND N/A
- EPS
- MHK 8.85
- ASND N/A
- Revenue
- MHK $10,812,015,000.00
- ASND $365,187,374.00
- Revenue This Year
- MHK N/A
- ASND $7.33
- Revenue Next Year
- MHK $1.95
- ASND $83.72
- P/E Ratio
- MHK $14.32
- ASND N/A
- Revenue Growth
- MHK N/A
- ASND 115.54
- 52 Week Low
- MHK $96.28
- ASND $111.09
- 52 Week High
- MHK $164.29
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- MHK 28.18
- ASND 62.94
- Support Level
- MHK $128.91
- ASND $128.45
- Resistance Level
- MHK $133.00
- ASND $141.48
- Average True Range (ATR)
- MHK 3.26
- ASND 4.52
- MACD
- MHK -0.62
- ASND 0.86
- Stochastic Oscillator
- MHK 1.84
- ASND 91.32
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.